Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Type I growth factor receptors: current status and future work

W J Gullick1

  • 1ICRF Oncology Unit, Hammersmith Hospital, London, U.K.

Biochemical Society Symposium
|March 26, 1998
PubMed
Summary

The epidermal growth factor receptor (EGFR) family, including ErbB-2, ErbB-3, and ErbB-4, plays a role in cancer. Mutations and overexpression of these receptors are linked to tumor development and treatment response.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Production of antisera to synthetic peptides.

Methods in molecular biology (Clifton, N.J.)·2011
Same author

Characterization of the cell membrane-associated products of the Neuregulin 4 gene.

Oncogene·2007
Same author

Proteomic identification of secreted proteins as surrogate markers for signal transduction inhibitor activity.

British journal of cancer·2007
Same author

Mutations of the epidermal growth factor receptor in non-small cell lung cancer -- search and destroy.

European journal of cancer (Oxford, England : 1990)·2005
Same author

Clinical value of epidermal growth factor receptor expression in primary breast cancer.

Advances in anatomic pathology·2005
Same author

Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment.

Endocrine-related cancer·2005

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The type 1 family of growth factor receptors comprises EGFR, ErbB-2, ErbB-3, and ErbB-4.
  • These receptors interact with various ligands, including EGFR-specific ligands and neuregulins.
  • Receptor function is mediated through heterodimeric pairs, influenced by ligand availability and receptor concentrations.

Purpose of the Study:

  • To review the role of the type 1 family of growth factor receptors in human cancers.
  • To highlight the significance of receptor alterations in tumor development and treatment.

Main Methods:

  • Literature review of studies on EGFR family receptors in cancer.
  • Analysis of receptor expression, mutation status, and ligand interactions.

Main Results:

  • Overexpression of EGFR, ErbB-2, and ErbB-3 is common in solid human tumors.
  • EGFR mutations are implicated in brain tumors and potentially other cancer types.
  • Altered receptor activity contributes to malignant transformation and influences disease progression.

Conclusions:

  • Alterations in EGFR family receptors are crucial in cancer development.
  • These receptor changes offer insights into disease prognosis and therapeutic strategies.
  • EGFR family members represent promising targets for novel cancer therapies.

Related Experiment Videos